“The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells” (2001) Swiss Medical Weekly, 131(0304), pp. 41–46. doi:10.4414/smw.2001.06144.